Hepatitis C treatment isn't pretty, but the dark days of weekly injections, rough side effects and no guarantee of full recovery from the liver-damaging disease may soon be over, researchers report. Two studies, both published in the Jan. ...
People with type 2 diabetes might be at somewhat higher risk of developing liver cancer, according to a large, long-term study. The research suggests that those with type 2 diabetes have about two to three times greater risk of developing ...
Tags: type 2 diabetes, liver cancer, hepatocellular carcinoma
Following U.S. Food and Drug Administration actions, USPLabs in Texas recalled and destroyed a supplement linked to liver failure and hepatitis, officials say. "As soon as we suspected a possible link between OxyElite Pro products and ...
Abbott has introduced FDA-approved hepatitis C virus (HCV) genotyping test for patients in the US. The completely automated RealTime HCV Genotype II test determines the specific type or strain of the HCV virus present in the blood of an ...
Tags: US, Health&Medicine, Abbott
Advanced Biological Laboratories (ABL) has acquired all the assets of Evivar Medical (Evivar), which includes its Hepatitis B virus (HBV) and C (HCV) web-based decision support tools and the associated viral genome analysis systems (SeqHepB ...
bioMérieux has recently launched the new CE-marked VIDAS® Anti-HCV test for the detection of antibodies to the hepatitis C virus (HCV), extending the Company’s current product range to provide a complete test menu for ...
Tags: Anti HCV Test, Viral Hepatitis, immunoassay platform, fluorescent assay
Advanced Biological Laboratories (ABL) has received CE mark approval for its DeepChek and ViroScore Suite clinical genotyping solutions. The approval is based on several evaluations of the company's next generation sequencing (NGS) ...
Tags: Advanced Biological, ABL, CE mark approval, evaluations